Yield Growth Announces Initial FDA Compliant Tests Indicate an SPF of 30 for Urban Juve’s Sunscreen Formula
December 31, 2018
VANCOUVER, British Columbia, Dec. 31, 2018 (GLOBE NEWSWIRE) — The Yield Growth Corp. (CSE:BOSS)announces that its proprietary sunscreen formula has passed the United States Federal Drug Agency (FDA) broad spectrum test which provides a clinical vitro measurement to confirm the ability of the product to perform against both ultraviolet A... Read more
High Hampton Holdings Corp. Reports the Fourth Quarter 2018 Financial Results and Provides an Operational and Corporate Update
December 28, 2018
TORONTO, Dec. 28, 2018 CSE: HCOTC: HHPHFFSE: 0HCN TORONTO, Dec. 28, 2018 /CNW/ – High Hampton Holdings Corp. (CSE: HC) (FSE: 0HCN) (“High Hampton” or the “Company”) today announced that it has filed its Consolidated Audited Financial Statements for the year ended August 31, 2018. The Consolidated Financial Statements... Read more
Future Farm Selected as Finalist in Florida for Hemp Research and CBD Product Development
December 28, 2018
Ryan Allway December 28th, 2018 News, Top News Vancouver, British Columbia, Dec. 28, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — In response to the recent passage of the 2018 U.S. Farm Bill, Future Farm Technologies Inc. (the “Company” or “Future Farm”) (CSE: FFT) (OTCQB: FFRMF) is pleased to... Read more
Weekend Unlimited Inc. Year End Letter to Shareholders
December 28, 2018
Ryan Allway December 28th, 2018 News, Top News Newly Appointed President and CEO, Paul Chu, Provides Shareholders with Update on Acquisition Phase and Revenue Focus for 2019 VANCOUVER,BC / ACCESSWIRE / December 28, 2018 / Mr. Paul Chu, President & Chief Executive Officer of WeekendUnlimited Inc. (“Weekend” or... Read more
Yield Growth Announces 9 new products, pass stability testing
December 27, 2018
Ryan Allway December 27th, 2018 News, Top News VANCOUVER, British Columbia, Dec. 27, 2018 (GLOBE NEWSWIRE) — The Yield Growth Corp. (CSE:BOSS) announces that the following 9 new products have completed stability and preservative challenge tests in accordance Health Canada regulations: Sunscreen Pain balm Sports spray Topical analgesic... Read more
Chemesis International Inc. Closes Second Tranche of Financing for Total Proceeds of $1,750,000
December 27, 2018
Ryan Allway December 27th, 2018 With the closing of the second tranche, the company has closed a total of $3,750,000 in financing VANCOUVER, British Columbia, Dec. 27, 2018 (GLOBE NEWSWIRE) — Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), announces that it has... Read more
Yield Growth Poised to Launch Urban Juve Products in the United States With Passage of US Farm Bill
December 24, 2018
Ryan Allway December 24th, 2018 News, Top News VANCOUVER, British Columbia, Dec. 24, 2018 (GLOBE NEWSWIRE) — The Yield Growth Corp. (CSE:BOSS) announces that it will soon commence sales of its Urban Juve hemp oil-infused personal care products to consumers in the US now that the US 2018... Read more
MediPharm Labs Increases Annual Production Capacity by 50% Up to 150,000KG; Positioned to Meet Significant Demand for Purified Cannabis Concentrates and Oil
December 24, 2018
Ryan Allway December 24th, 2018 News, Top News TORONTO, Dec. 24, 2018 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (the “Company” or “MediPharm Labs”) is pleased to announce that its wholly-owned subsidiary, MediPharm Labs Inc. (“MediPharm”), has received approval from Health Canada to increase its current annual... Read more
Ryan Allway December 21st, 2018 VANCOUVER, DECEMBER 21, 2018 – Next Green Wave (“NGW” or the “Company”) (CSE: NGW) (OTCQB: NXGWF), a Canadian based California operating cannabis company established to provide premium products and brands to both medicinal and adult use consumers in the California market, today announced... Read more
FSD Pharma Responds to Therapix Termination of Binding LOI
December 21, 2018
Ryan Allway December 21st, 2018 FSD Pharma Inc. (“FSD Pharma” or “FSD”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) in response to Therapix Biosciences’ termination of the company’s binding letter of intent (LOI) to be acquired by FSD Pharma, Dr. Raza Bokhari, Executive Co-Chairman of the Board of FSD... Read more
